Reasons to invest
Reason No. 5: We have embarked on a clear path towards profitable growth
- We have been on a clear growth track again for the last two years. We aim to double the Group’s revenue in the medium term while at the same time increasing the adjusted EBITDA margin.
- The BioProducts area is the Group’s primary growth segment. We have already invested heavily in expanding production capacity at our sites in recent years.
- Our growth strategy is geographically focused on Europe and North America.
- We offer highly innovative solutions and products for our customers through the close integration of our biotechnological research and production expertise.